NO982227L - Urogenitalcarcinom-TPL komplekspeptider og antistoffer derav - Google Patents
Urogenitalcarcinom-TPL komplekspeptider og antistoffer deravInfo
- Publication number
- NO982227L NO982227L NO982227A NO982227A NO982227L NO 982227 L NO982227 L NO 982227L NO 982227 A NO982227 A NO 982227A NO 982227 A NO982227 A NO 982227A NO 982227 L NO982227 L NO 982227L
- Authority
- NO
- Norway
- Prior art keywords
- tpl
- antibodies
- urogenital
- complex peptides
- urogenital carcinoma
- Prior art date
Links
- 201000009030 Carcinoma Diseases 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT96RM000496A IT1284870B1 (it) | 1996-07-10 | 1996-07-10 | Peptidi dei complessi tlp da carcinomi dell'apparato urogenitale e anticorpi diretti contro di essi |
PCT/IT1997/000158 WO1998001462A2 (en) | 1996-07-10 | 1997-07-02 | Urogenital carcinoma tlp complex peptides and antibodies thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NO982227L true NO982227L (no) | 1998-05-15 |
NO982227D0 NO982227D0 (no) | 1998-05-15 |
Family
ID=11404336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO982227A NO982227D0 (no) | 1996-07-10 | 1998-05-15 | Urogenitalcarcinom-TPL komplekspeptider og antistoffer derav |
Country Status (16)
Country | Link |
---|---|
US (3) | US6222010B1 (de) |
EP (1) | EP0851872B1 (de) |
CN (1) | CN1136230C (de) |
AT (1) | ATE200678T1 (de) |
AU (1) | AU716721B2 (de) |
CA (1) | CA2234151C (de) |
DE (1) | DE69704606T2 (de) |
DK (1) | DK0851872T3 (de) |
ES (1) | ES2156393T3 (de) |
GR (1) | GR3036057T3 (de) |
IT (1) | IT1284870B1 (de) |
NO (1) | NO982227D0 (de) |
PT (1) | PT851872E (de) |
RU (1) | RU2203679C2 (de) |
SK (1) | SK47098A3 (de) |
WO (1) | WO1998001462A2 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1284870B1 (it) | 1996-07-10 | 1998-05-22 | Ist Farmacoterapico It Spa | Peptidi dei complessi tlp da carcinomi dell'apparato urogenitale e anticorpi diretti contro di essi |
DE10001717C1 (de) * | 2000-01-18 | 2001-04-26 | Xcellsis Gmbh | Brennstoffzellensystem |
ITMI20011380A1 (it) * | 2001-06-29 | 2002-12-29 | Unihart Corp | Antigene tlp e sue applicazioni diagnostiche |
CN101712946B (zh) * | 2009-09-27 | 2013-02-27 | 南通大学附属医院 | 构建生殖结节器官培养尿道体外发育模型的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1206250B (it) | 1987-02-18 | 1989-04-14 | Ist Farmacoterapico It Spa | Stiche umane e relativi prodotti metodo per l'estrazione di antigeni di membrana aventi proprieta' immunogene a partire da cellule neopla- |
IT1262954B (it) | 1992-07-03 | 1996-07-23 | Ist Farmacoterapico It Spa | Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi. |
IT1284870B1 (it) | 1996-07-10 | 1998-05-22 | Ist Farmacoterapico It Spa | Peptidi dei complessi tlp da carcinomi dell'apparato urogenitale e anticorpi diretti contro di essi |
-
1996
- 1996-07-10 IT IT96RM000496A patent/IT1284870B1/it active IP Right Grant
-
1997
- 1997-07-02 WO PCT/IT1997/000158 patent/WO1998001462A2/en active IP Right Grant
- 1997-07-02 PT PT97932002T patent/PT851872E/pt unknown
- 1997-07-02 AU AU35572/97A patent/AU716721B2/en not_active Ceased
- 1997-07-02 CN CNB971912130A patent/CN1136230C/zh not_active Expired - Fee Related
- 1997-07-02 RU RU98106385/14A patent/RU2203679C2/ru not_active IP Right Cessation
- 1997-07-02 CA CA002234151A patent/CA2234151C/en not_active Expired - Fee Related
- 1997-07-02 US US09/051,357 patent/US6222010B1/en not_active Expired - Fee Related
- 1997-07-02 AT AT97932002T patent/ATE200678T1/de not_active IP Right Cessation
- 1997-07-02 SK SK470-98A patent/SK47098A3/sk unknown
- 1997-07-02 DE DE69704606T patent/DE69704606T2/de not_active Expired - Fee Related
- 1997-07-02 DK DK97932002T patent/DK0851872T3/da active
- 1997-07-02 EP EP97932002A patent/EP0851872B1/de not_active Expired - Lifetime
- 1997-07-02 ES ES97932002T patent/ES2156393T3/es not_active Expired - Lifetime
-
1998
- 1998-05-15 NO NO982227A patent/NO982227D0/no unknown
-
2000
- 2000-02-15 US US09/504,089 patent/US20030170750A1/en not_active Abandoned
- 2000-09-14 US US09/661,503 patent/US6664378B1/en not_active Expired - Fee Related
-
2001
- 2001-06-14 GR GR20010400899T patent/GR3036057T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT851872E (pt) | 2001-08-30 |
CA2234151C (en) | 2004-02-03 |
CA2234151A1 (en) | 1998-01-15 |
ITRM960496A1 (it) | 1998-01-10 |
US20030170750A1 (en) | 2003-09-11 |
EP0851872A3 (de) | 1998-10-14 |
WO1998001462A2 (en) | 1998-01-15 |
RU2203679C2 (ru) | 2003-05-10 |
WO1998001462A3 (en) | 1998-08-06 |
US6222010B1 (en) | 2001-04-24 |
DE69704606D1 (de) | 2001-05-23 |
ES2156393T3 (es) | 2001-06-16 |
CN1136230C (zh) | 2004-01-28 |
DE69704606T2 (de) | 2001-11-08 |
DK0851872T3 (da) | 2001-06-18 |
IT1284870B1 (it) | 1998-05-22 |
SK47098A3 (en) | 1999-02-11 |
EP0851872A2 (de) | 1998-07-08 |
CN1205012A (zh) | 1999-01-13 |
GR3036057T3 (en) | 2001-09-28 |
NO982227D0 (no) | 1998-05-15 |
AU3557297A (en) | 1998-02-02 |
AU716721B2 (en) | 2000-03-02 |
ATE200678T1 (de) | 2001-05-15 |
EP0851872B1 (de) | 2001-04-18 |
US6664378B1 (en) | 2003-12-16 |
ITRM960496A0 (de) | 1996-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK261386A (da) | Monoklonale antistoffer | |
EP1862472A3 (de) | Chlamydia-Protein, Gensequenz und Verwendung | |
DE69222956D1 (de) | Kleinste erkennungseinheit eines pem-mucin-"tandem repeat"-spezifischen monoklonalen antikoerpers | |
MX9708791A (es) | Gen de ataxia-telangiectasia y su organizacion genomica. | |
WO2002018443A3 (en) | A recombinant monoclonal antibody to phosphotyrosine-containing proteins | |
AU7683196A (en) | Peptide conjugates, use thereof as a drug, and compositions containing same | |
EP0875567A3 (de) | Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung | |
AU2002223044A1 (en) | Kit and method for detecting the esm-1 protein | |
ZA943920B (en) | Pharmaceutical compositions | |
CA2178635A1 (en) | Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form | |
NO982227L (no) | Urogenitalcarcinom-TPL komplekspeptider og antistoffer derav | |
CA2137280A1 (fr) | Clonage du gene codant pour la proteine gp28.5 de toxoplasma gondii; fragments peptidiques de cette proteine et leurs applications | |
CA2106563A1 (en) | Cocaine derivatives and protein and polypeptide cocaine derivative conjugates and labels | |
GB9816514D0 (en) | Novel method | |
AU641736B2 (en) | Delivery of agents | |
DE69311796D1 (de) | Peptide von dem caseinomacropeptid, antikorper dagegen und ihre andwendungen | |
DE69233666D1 (de) | Verzweigte Peptide zum Nachweis von Antikörpern | |
HK1031664A1 (en) | Use of an organ-specific nutritional composition | |
AU7896891A (en) | Trypsin inhibitor (alpha, at) peptide, immunoassay, monoclonal antibody and hybridoma | |
ATE46173T1 (de) | Pharmakologisch aktive peptide. | |
DE69733026D1 (de) | Cyclin e spezifische konstrukte und komplexe | |
FR2737209B1 (fr) | Peptide capable d'etre reconnu par des anticorps reconnaissant l'antigene c33 du virus de l'hepatite c | |
BR9801168A (pt) | Peptìdios de complexo de tlp de carcinoma urogenital e os seus anticorpos. | |
EP0371818A3 (de) | Peptide | |
AU9538501A (en) | A novel polypeptide-mouse transient receptor potential protein 2 (trp2)12 and the polynucleotide encoding said polypeptide |